Search research articles
Contact Us
Filters
Showing results (1-10 of 213) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2023
Adjuvant Chemotherapy in Older Women With Early Breast Cancer
Dario Trapani
Expert Review of Anticancer Therapy
|
April 17, 2020
How can biosimilars change the trajectory of breast cancer therapy?
Dario Trapani, Giuseppe Curigliano
The Lancet. Oncology
|
June 4, 2021
COVID-19 vaccines in patients with cancer
Dario Trapani, Giuseppe Curigliano
Recenti Progressi in Medicina
|
November 24, 2022
[Access to cancer treatment: financial difficulties, system sustainability, methodological rigor. The role of scientific journals.]
Raffaele Giusti, Dario Trapani
Journal of Cancer Policy
|
May 13, 2022
The global landscape of drug development of trastuzumab biosimilars
Dario Trapani, Giuseppe Curigliano
Internal and Emergency Medicine
|
August 22, 2015
Antibiotic treatment strategies for community-acquired pneumonia in adults
Dario Trapani, Mattia Bonzi,
The Lancet Regional Health. Europe
|
May 8, 2026
Advancing oncology innovation under persistent constraints
Dario Trapani, Giuseppe Curigliano
Nature Reviews. Clinical Oncology
|
June 26, 2026
Patient value over patent value: the mandate for open-source oncology
Bibek Aryal, Dario Trapani
Breast (Edinburgh, Scotland)
|
December 18, 2021
Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021
Dario Trapani, Giuseppe Curigliano
Current Opinion in Oncology
|
August 23, 2020
How to treat lobular cancer in the adjuvant setting?
Dario Trapani, Giuseppe Curigliano
Page
of 22
Search research articles
Search
Showing results (1-10 of 213) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2023
Adjuvant Chemotherapy in Older Women With Early Breast Cancer
Dario Trapani
Expert Review of Anticancer Therapy
|
April 17, 2020
How can biosimilars change the trajectory of breast cancer therapy?
Dario Trapani, Giuseppe Curigliano
The Lancet. Oncology
|
June 4, 2021
COVID-19 vaccines in patients with cancer
Dario Trapani, Giuseppe Curigliano
Recenti Progressi in Medicina
|
November 24, 2022
[Access to cancer treatment: financial difficulties, system sustainability, methodological rigor. The role of scientific journals.]
Raffaele Giusti, Dario Trapani
Journal of Cancer Policy
|
May 13, 2022
The global landscape of drug development of trastuzumab biosimilars
Dario Trapani, Giuseppe Curigliano
Internal and Emergency Medicine
|
August 22, 2015
Antibiotic treatment strategies for community-acquired pneumonia in adults
Dario Trapani, Mattia Bonzi,
The Lancet Regional Health. Europe
|
May 8, 2026
Advancing oncology innovation under persistent constraints
Dario Trapani, Giuseppe Curigliano
Nature Reviews. Clinical Oncology
|
June 26, 2026
Patient value over patent value: the mandate for open-source oncology
Bibek Aryal, Dario Trapani
Breast (Edinburgh, Scotland)
|
December 18, 2021
Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021
Dario Trapani, Giuseppe Curigliano
Current Opinion in Oncology
|
August 23, 2020
How to treat lobular cancer in the adjuvant setting?
Dario Trapani, Giuseppe Curigliano
Page
of 22